BEAUTY DNA LIMITED

The company experienced three director resignations in its final twelve months, leaving just one active director out of four total appointments since 2011. This abrupt reduction in leadership stability occurred despite an historical average director tenure of 6.5 years. Such rapid board consolidation often indicates that a business is preparing for winding up or liquidation proceedings.

Full accounts were filed as recently as 23 March 2026, exactly one month before the company entered creditors' voluntary liquidation on 23 April 2026. This timeline shows that compliance obligations were maintained right up to the point of insolvency. For creditors, the publication of final accounts can provide critical, near term clarity on the assets and liabilities of the business.

The transition to liquidation was executed under Notice 5118032, with Stephen Katz of BTG Begbies Traynor appointed as one of two joint liquidators. This voluntary route, initiated by both members and creditors, allows for an orderly winding up of affairs. Engaging qualified insolvency practitioners, such as IP 8681, ensures that statutory distributions and asset realisations are handled in accordance with the Insolvency Act 1986.

This case illustrates a pattern where a long standing company maintains its regulatory filings up to the final weeks, whilst experiencing a rapid depletion of its board of directors shortly before entering a formal creditors' voluntary liquidation.